CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Prevail Global Study [NA]
Summary
This document reports that the Prevail Global Study by Medtronic Vascular is currently recruiting participants for coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: RECRUITING